This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
4b11
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
| - | [[ | + | ==Plasmodium vivax N-myristoyltransferase with a bound benzofuran inhibitor (compound 13)== |
| + | <StructureSection load='4b11' size='340' side='right' caption='[[4b11]], [[Resolution|resolution]] 1.59Å' scene=''> | ||
| + | == Structural highlights == | ||
| + | <table><tr><td colspan='2'>[[4b11]] is a 3 chain structure with sequence from [http://en.wikipedia.org/wiki/Plasmodium_vivax Plasmodium vivax]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4B11 OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4B11 FirstGlance]. <br> | ||
| + | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=7I1:3-METHYL-N-(NAPHTHALEN-1-YLMETHYL)-4-PIPERIDIN-4-YLOXY-1-BENZOFURAN-2-CARBOXAMIDE'>7I1</scene>, <scene name='pdbligand=CL:CHLORIDE+ION'>CL</scene>, <scene name='pdbligand=DMS:DIMETHYL+SULFOXIDE'>DMS</scene>, <scene name='pdbligand=MG:MAGNESIUM+ION'>MG</scene>, <scene name='pdbligand=NHW:2-OXOPENTADECYL-COA'>NHW</scene>, <scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene></td></tr> | ||
| + | <tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[4a95|4a95]], [[4b10|4b10]], [[4b12|4b12]], [[4b13|4b13]], [[4b14|4b14]]</td></tr> | ||
| + | <tr id='activity'><td class="sblockLbl"><b>Activity:</b></td><td class="sblockDat"><span class='plainlinks'>[http://en.wikipedia.org/wiki/Glycylpeptide_N-tetradecanoyltransferase Glycylpeptide N-tetradecanoyltransferase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=2.3.1.97 2.3.1.97] </span></td></tr> | ||
| + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4b11 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4b11 OCA], [http://www.rcsb.org/pdb/explore.do?structureId=4b11 RCSB], [http://www.ebi.ac.uk/pdbsum/4b11 PDBsum]</span></td></tr> | ||
| + | </table> | ||
| + | <div style="background-color:#fffaf0;"> | ||
| + | == Publication Abstract from PubMed == | ||
| + | Design of inhibitors for N-myristoyltransferase (NMT), an enzyme responsible for protein trafficking in Plasmodium falciparum , the most lethal species of parasites that cause malaria, is described. Chemistry-driven optimization of compound 1 from a focused NMT inhibitor library led to the identification of two early lead compounds 4 and 25, which showed good enzyme and cellular potency and excellent selectivity over human NMT. These molecules provide a valuable starting point for further development. | ||
| - | + | Design and Synthesis of Inhibitors of Plasmodium falciparum N-Myristoyltransferase, A Promising Target for Antimalarial Drug Discovery.,Yu Z, Brannigan JA, Moss DK, Brzozowski AM, Wilkinson AJ, Holder AA, Tate EW, Leatherbarrow RJ J Med Chem. 2012 Oct 15. PMID:23035716<ref>PMID:23035716</ref> | |
| - | + | From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | |
| - | + | </div> | |
| - | + | == References == | |
| - | == | + | <references/> |
| - | + | __TOC__ | |
| + | </StructureSection> | ||
[[Category: Glycylpeptide N-tetradecanoyltransferase]] | [[Category: Glycylpeptide N-tetradecanoyltransferase]] | ||
[[Category: Plasmodium vivax]] | [[Category: Plasmodium vivax]] | ||
| - | [[Category: Brannigan, J A | + | [[Category: Brannigan, J A]] |
| - | [[Category: Brzozowski, A M | + | [[Category: Brzozowski, A M]] |
| - | [[Category: Holder, A A | + | [[Category: Holder, A A]] |
| - | [[Category: Leatherbarrow, R J | + | [[Category: Leatherbarrow, R J]] |
| - | [[Category: Moss, D K | + | [[Category: Moss, D K]] |
| - | [[Category: Tate, E W | + | [[Category: Tate, E W]] |
| - | [[Category: Wilkinson, A J | + | [[Category: Wilkinson, A J]] |
| - | [[Category: Yu, Z | + | [[Category: Yu, Z]] |
[[Category: Drug design]] | [[Category: Drug design]] | ||
[[Category: Malaria]] | [[Category: Malaria]] | ||
[[Category: Myristoyltransferase]] | [[Category: Myristoyltransferase]] | ||
[[Category: Transferase]] | [[Category: Transferase]] | ||
Revision as of 14:46, 9 December 2014
Plasmodium vivax N-myristoyltransferase with a bound benzofuran inhibitor (compound 13)
| |||||||||||
